Analgesic and antipyretic

21 marketed 9 in Phase 3

This page covers all Analgesic and antipyretic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Cyclooxygenase (COX) enzymes, Cyclooxygenase (COX) enzymes; possibly TRPV1 and other pain pathways, Cyclooxygenase (COX), primarily central nervous system isoforms.

Targets

Cyclooxygenase (COX) enzymes · Cyclooxygenase (COX) enzymes; possibly TRPV1 and other pain pathways · Cyclooxygenase (COX), primarily central nervous system isoforms · Cyclooxygenase (COX) · Cyclooxygenase (COX), primarily in central nervous system · Cyclooxygenase (COX-1, COX-2) · Cyclooxygenase (COX) enzymes (central nervous system) · Cyclooxygenase (COX) enzymes; central pain and temperature regulation pathways

Marketed (21)

Phase 3 pipeline (9)